Roundup Cancer Lawsuit News

The Third Monsanto Glyphosate Cancer Trial is Underway

Two bellwether trials that have been decided in the plaintiff's favor have paved the way for many more to come

Monday, April 1, 2019 - Septuagenarians Alva and Alberta Pilliod, suffering from non-Hodgkin's lymphoma that has spread to the couple's brain and pelvis respectively, have filed a claim against Monsanto. The couple alleges that their long-term use of Roundup herbicide contributed to their cancer. The facts surrounding the trial is similar to the previous two trials in that the couple has said that they relied on Roundup's printed information that states that Roundup's active ingredient, glyphosate, is safe for human use and that if they knew the chemical was linked to causing cancer they would not have used it. The Pilliods are also concerned with the disease and death Roundup may have also caused to the wildlife that roams on their property. Their trial which began today in Oakland California, and is expected to last around one month is the third against the agro-chemical giant. The previous two were decided unanimously against Monsanto with Jury awards of $78 million in one, and $80 million in the other. Monsanto Roundup cancer attorneys offer a no obligation, free consultation to families and individuals in the United States before filing a claim.

The most recent trial was decided last week for Edwin Hardeman who contracted cancer from spraying Roundup herbicide on his 50-acre property for decades and against Monsanto for failing to warn Hardeman of Roundup's cancer risks. The trial was unique in that Judge Chhabria split the trial into two phases in response to Monsanto's demands so that jurors would not be confused or inflamed by the plaintiff's claims of corporate fraud. The first phase was to limit evidence to that of a scientific nature, and the second to allow evidence of internal Monsanto memos that show the company has known for decades that glyphosate causes cancer and went to great and expensive lengths to cover up or discredit anyone who claimed glyphosate was not safe.

First up on Monsanto's hit list of scientific organizations to be discredited was the International Agency on Research on Cancer (IARC), a division of the independent and prestigious World Health Organization located in Lyon, France. In 2015, the IARC issued a statement that put glyphosate in the next to the highest alert category stating that the chemical was "probably carcinogenic to humans." According to the website US Right to "Documents that have come to light through discovery show the company discussing using third parties who appeared to be independent of Monsanto to publicly criticize IARC and push Monsanto propaganda points. The internal Monsanto records show the company's role in ghostwriting an article that appeared on Forbes' contributors' platform, and they show that the company was behind a story published by Reuters in 2017 that falsely claimed an IARC scientist withheld information from IARC that would have changed the classification."

In a nutshell, Monsanto's strategy to divide and conquer by splitting the trial into two backfired miserably. Not only did jurors get to concentrate on expert witness testimony and the findings of the IARC, but they also were able to give their undivided attention to the lengths in which Monsanto was willing to go to cover up what they knew and to squash any publication that claimed glyphosate was not safe. The result was an $80 million jury award.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.